96 Days
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
96 Daysالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
96 DaysReady to play
Ready to play
An international clinical trial revealed that the oral medication "Eliquisolibreon" demonstrates significant effectiveness in treating type 2 diabetes. It resulted in weight loss of up to 5% of body weight and improved blood sugar levels after 26 weeks. The drug, belonging to the class of GLP-1 receptor agonists, enhances insulin secretion and slows gastric emptying. It now offers a competitive advantage as it is taken orally instead of by injection.
Notice: This Is an AI-Generated Summary
Comments (0)